Free Trial

Kiromic BioPharma (KRBP) SEC Filings & 10K Form

Kiromic BioPharma logo
$1.15
+0.14 (+13.86%)
(As of 10/31/2024 ET)

Recent Kiromic BioPharma SEC Filings

DateFilerForm TypeView
09/30/2024
3:29 PM
Kiromic BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/26/2024
5:44 PM
BERSANI PIETRO (Reporting)
Kiromic BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
2:04 PM
Kiromic BioPharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/09/2024
7:01 PM
Kiromic BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2024
3:30 PM
Kiromic BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
4:21 PM
Kiromic BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
5:32 PM
Kiromic BioPharma (Issuer)
Misajon Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:30 PM
Hungerford Brian (Reporting)
Kiromic BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
3:35 PM
BERSANI PIETRO (Reporting)
Kiromic BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
3:36 PM
Hungerford Brian (Reporting)
Kiromic BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
3:36 PM
Kiromic BioPharma (Issuer)
Misajon Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
3:37 PM
Kiromic BioPharma (Issuer)
NAGEL MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:30 PM
Kiromic BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2024
4:00 PM
Kiromic BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2024
5:29 AM
Kiromic BioPharma (Filer)
Form ARS
05/20/2024
5:29 AM
Kiromic BioPharma (Filer)
Form ARS
05/10/2024
9:37 AM
Kiromic BioPharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
4:29 PM
Kiromic BioPharma (Issuer)
Mirandola Leonardo (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/09/2024
4:00 PM
BERSANI PIETRO (Filed by)
Kiromic BioPharma (Subject)
Form SC 13D/A
05/07/2024
5:17 PM
Hungerford Brian (Reporting)
Kiromic BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
4:30 PM
Kiromic BioPharma (Filer)
Form PRE 14A
05/07/2024
4:00 PM
BERSANI PIETRO (Reporting)
Kiromic BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
3:30 PM
Kiromic BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2024
3:30 PM
Kiromic BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
3:30 PM
Kiromic BioPharma (Filer)
Form RW
04/05/2024
3:30 PM
Kiromic BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2024
4:21 PM
Kiromic BioPharma (Filer)
Form 10-K/A
03/20/2024
4:58 PM
Catlin Michael (Reporting)
Kiromic BioPharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
4:55 PM
Kiromic BioPharma (Issuer)
NAGEL MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
4:57 PM
Kiromic BioPharma (Issuer)
Misajon Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
3:30 PM
Kiromic BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2024
8:56 PM
Kiromic BioPharma (Subject)
YA II PN, Ltd. (Filed by)
Form SC 13G/A
01/11/2024
3:15 PM
Kiromic BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
9:25 AM
Empery Asset Management, LP (Filed by)
Kiromic BioPharma (Subject)
Form SC 13G/A
11/20/2023
7:46 AM
Kiromic BioPharma (Subject)
Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
11/09/2023
8:49 AM
Kiromic BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2023
3:30 PM
Kiromic BioPharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:KRBP) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners